Treatment of irritable bowel syndrome with molybdenum
US12226433B2 · kind B2 · utility
0Cited by
14References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2019 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | Jul 22, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are methods for treating or preventing IBS in subjects by administering molybdenum or a salt thereof to subjects having or prone of getting IBS. The molybdenum has been shown to treat or prevent IBS in subjects administered this agent when compared to reference subjects not administered molybdenum.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.